Nicole Walker
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Fund: $250M
Arboretum Ventures thesis
All Current Investments Life Science Tools/Diagnostics Medical Devices Pharma Adjacencies Tech-Enabled Care Delivery Exits Life Science Tools/Diagnostics Medical Devices Pharma Adjacencies Tech-Enabled Care Delivery Accuri Cytometers Acquired by Becton, Dickinson and Company, March 2011 Accuri Cytometers BioIQ Acquired by LetsGetChecked, May 2022 BioIQ CardioMEMS Acquired by St. Jude Medical, June 2014 CardioMEMS Dropworks Acquired by Bio-Rad Laboratories, October 2021 Dropworks Esperion Therapeutics Completed Initial Public Offering on June 26, 2013. Esperion Therapeutics EQRx Completed a SPA
Sector and stage focus
- Series A: Consumer Health, BioTech, Health IT, Health & Hospital Services, Digital Health
- Seed: BioTech, Consumer Health, Health IT, Digital Health, Health & Hospital Services
- general: Diverse Investors, Female Investors, Midwest
Is Nicole Walker a fit for your round?
Upload your pitch deck and see whether Nicole Walker appears in your top 20 matches.
Find investors for your deck